Risk of incident and fatal melanoma in individuals with a family history of incident or fatal melanoma or any cancer

British Journal of Dermatology

Volumn 165, Issue 2, 2011, Pages 342-348

  Brandt, A ^a   Sundquist, J ^b,c   Hemminki, K ^a,c  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b LUND UNIVERSITY   (Sweden)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER MORTALITY; CANCER RISK; COLORECTAL CANCER; DATA BASE; ESOPHAGUS CANCER; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; HUMAN; KIDNEY CANCER; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; MELANOMA; MYELOMA; PANCREAS CANCER; PARENT; PRIORITY JOURNAL; PROGENY; PROSTATE CANCER; SIBLING; STANDARDIZED INCIDENCE RATIO;

ADULT; AGED; CAUSE OF DEATH; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; MALE; MELANOMA; MIDDLE AGED; NEOPLASMS; PEDIGREE; RISK FACTORS; SKIN NEOPLASMS; SWEDEN;

EID: 79960637237     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2011.10350.x     Document Type: Article

References (17)

1. Goldstein AM, Chan M, Harland M, et al. High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumours, and uveal melanoma across GenoMEL. Cancer Res 2006; 66: 9818-28. (Pubitemid 44672032)
2. Hemminki K, Zhang H, Czene K,. Familial and attributable risks in cutaneous melanoma: effects of proband and age. J Invest Dermatol 2003; 120: 217-23. (Pubitemid 36513070)
3. Larson AA, Leachman SA, Eliason MJ, et al. Population-based assessment of non-melanoma cancer risk in relatives of cutaneous melanoma probands. J Invest Dermatol 2007; 127: 183-8. (Pubitemid 46005677)
4. Amundadottir LT, Thorvaldsson S, Gudbjartsson DF, et al. Cancer as a complex phenotype: pattern of cancer distribution within and beyond the nuclear family. PLoS Med 2004; 1: e65.
5. Florell SR, Boucher KM, Garibotti G, et al. Population-based analysis of prognostic factors and survival in familial melanoma. J Clin Oncol 2005; 23: 7168-77.
6. Hemminki K, Li X, Plna K, et al. The nation-wide Swedish Family-Cancer Database-updated structure and familial rates. Acta Oncol 2001; 40: 772-7. (Pubitemid 33081988)
7. Centre for Epidemiology. Cancer Incidence in Sweden 2006. Stockholm: The National Board of Health and Welfare, 2007.
8. Johansson LA, Bjorkenstam C, Westerling R,. Unexplained differences between hospital and mortality data indicated mistakes in death certification: an investigation of 1,094 deaths in Sweden during 1995. J Clin Epidemiol 2009; 62: 1202-9.
9. Johansson LA, Westerling R,. Comparing Swedish hospital discharge records with death certificates: implications for mortality statistics. Int J Epidemiol 2000; 29: 495-502. (Pubitemid 30447254)
10. Lindholm C, Andersson R, Dufmats M, et al. Invasive cutaneous malignant melanoma in Sweden, 1990-1999. A prospective, population-based study of survival and prognostic factors. Cancer 2004; 101: 2067-78. (Pubitemid 39425384)
11. Bermejo JL, Hemminki K,. Familial risk of cancer shortly after diagnosis of the first familial tumour. J Natl Cancer Inst 2005; 97: 1575-9. (Pubitemid 41662711)
12. Shah M, Zhu K, Palmer RC, et al. Family history of cancer and utilization of prostate, colorectal and skin cancer screening tests in U.S. men. Prev Med 2007; 44: 459-64. (Pubitemid 46691319)
13. Gould Rothberg BE, Bracken MB, Rimm DL,. Tissue biomarkers for prognosis in cutaneous melanoma: a systematic review and meta-analysis. J Natl Cancer Inst 2009; 101: 452-74.
14. Cannon-Albright LA, Meyer LJ, Goldgar DE, et al. Penetrance and expressivity of the chromosome 9p melanoma susceptibility locus (MLM). Cancer Res 1994; 54: 6041-4. (Pubitemid 24378624)
15. Berwick M, Orlow I, Hummer AJ, et al. The prevalence of CDKN2A germ-line mutations and relative risk for cutaneous malignant melanoma: an international population-based study. Cancer Epidemiol Biomarkers Prev 2006; 15: 1520-5. (Pubitemid 44299326)
16. Hemminki K, Li X,. Association of brain tumours with other neoplasms in families. Eur J Cancer 2004; 40: 253-9. (Pubitemid 38077028)
17. Eliason MJ, Larson AA, Florell SR, et al. Population-based prevalence of CDKN2A mutations in Utah melanoma families. J Invest Dermatol 2006; 126: 660-6. (Pubitemid 43255657)